Showing results (1841-1850 of 2,694) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|June 3, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialFrank Bähner, Saul N Faust, Leela R L Davies, et al.The Lancet. Infectious Diseases|June 8, 2026
Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in AustraliaNicole M White, Philip L Russo, Georgia Matterson, et al.The Lancet. Infectious Diseases|May 31, 2023
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort studyMartin Hoenigl, Jon Salmanton-García, Matthias Egger, et al.The Lancet. Infectious Diseases|September 28, 2020
Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silentAshley Hirons, Georges Khoury, Damian F J PurcellThe Lancet. Infectious Diseases|May 29, 2026
Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trialRodney Dawson, Andreas H Diacon, Ebrahim Variava, et al.The Lancet. Infectious Diseases|April 27, 2010
Rhodococcus equi infectionAlexandra V Yamshchikov, Audrey Schuetz, G Marshall LyonThe Lancet. Infectious Diseases|December 3, 2013
A possible outbreak of swine influenza, 1892David M Morens, Jeffery K TaubenbergerThe Lancet. Infectious Diseases|May 10, 2026
Durability of doxycycline effectiveness against gonorrhoea after implementation of post-exposure prophylaxis in southern California, USA: a retrospective, test-negative, observational studyMatan Yechezkel, David Helekal, Banshri Kapadia, et al.The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.The Lancet. Infectious Diseases|May 3, 2026
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort studyAmanda C Miles, Jelena Vojicic, Paula Peyrani, et al.Pageof 270